|
AU4815197A
(en)
|
1996-10-09 |
1998-05-05 |
Pharmasset, Ltd. |
Tetraphosphonate bicyclic trisanhydrides
|
|
EP0981534B1
(en)
|
1997-02-06 |
2006-05-03 |
Inspire Pharmaceuticals, Inc. |
Dinucleotides and their uses
|
|
US7223744B2
(en)
|
1997-02-10 |
2007-05-29 |
Inspire Pharmaceuticals, Inc. |
Pharmaceutical formulation comprising dinucleoside polyphosphates and salts thereof
|
|
US20040181078A1
(en)
*
|
1997-10-10 |
2004-09-16 |
Pharmasset, Ltd. |
Tetraphosphonate bicyclic trisanhydrides
|
|
WO2001044260A2
(en)
*
|
1999-12-17 |
2001-06-21 |
Ariad Pharmaceuticals, Inc. |
Novel purines
|
|
US7115589B2
(en)
|
1999-12-17 |
2006-10-03 |
Ariad Pharmaceuticals, Inc. |
Purine derivatives
|
|
US6787526B1
(en)
|
2000-05-26 |
2004-09-07 |
Idenix Pharmaceuticals, Inc. |
Methods of treating hepatitis delta virus infection with β-L-2′-deoxy-nucleosides
|
|
US6875751B2
(en)
|
2000-06-15 |
2005-04-05 |
Idenix Pharmaceuticals, Inc. |
3′-prodrugs of 2′-deoxy-β-L-nucleosides
|
|
US6867199B2
(en)
|
2000-08-21 |
2005-03-15 |
Inspire Pharmaceuticals, Inc. |
Dinucleoside polyphosphate compositions and their therapeutic use
|
|
US6555675B2
(en)
|
2000-08-21 |
2003-04-29 |
Inspire Pharmaceuticals, Inc. |
Dinucleoside polyphosphate compositions and their therapuetic use as purinergic receptor agonists
|
|
JP2005502580A
(ja)
*
|
2000-12-15 |
2005-01-27 |
フアーマセツト・リミテツド |
フラビウィルス感染治療用抗ウィルス薬
|
|
US7452901B2
(en)
|
2003-04-25 |
2008-11-18 |
Gilead Sciences, Inc. |
Anti-cancer phosphonate analogs
|
|
WO2004096285A2
(en)
|
2003-04-25 |
2004-11-11 |
Gilead Sciences, Inc. |
Anti-infective phosphonate conjugates
|
|
SG182849A1
(en)
|
2003-04-25 |
2012-08-30 |
Gilead Sciences Inc |
Antiviral phosphonate analogs
|
|
US7427636B2
(en)
|
2003-04-25 |
2008-09-23 |
Gilead Sciences, Inc. |
Inosine monophosphate dehydrogenase inhibitory phosphonate compounds
|
|
US7432261B2
(en)
|
2003-04-25 |
2008-10-07 |
Gilead Sciences, Inc. |
Anti-inflammatory phosphonate compounds
|
|
US7470724B2
(en)
|
2003-04-25 |
2008-12-30 |
Gilead Sciences, Inc. |
Phosphonate compounds having immuno-modulatory activity
|
|
EP1620109A2
(en)
|
2003-04-25 |
2006-02-01 |
Gilead Sciences, Inc. |
Kinase inhibitor phosphonate conjugates
|
|
US7407965B2
(en)
|
2003-04-25 |
2008-08-05 |
Gilead Sciences, Inc. |
Phosphonate analogs for treating metabolic diseases
|
|
WO2005002626A2
(en)
|
2003-04-25 |
2005-01-13 |
Gilead Sciences, Inc. |
Therapeutic phosphonate compounds
|
|
RU2358979C2
(ru)
|
2003-05-30 |
2009-06-20 |
Фармассет, Инк. |
Модифицированные фторированные аналоги нуклеозида
|
|
WO2005044279A1
(en)
|
2003-10-24 |
2005-05-19 |
Gilead Sciences, Inc. |
Purine nucleoside phosphonate conjugates
|
|
US7432273B2
(en)
|
2003-10-24 |
2008-10-07 |
Gilead Sciences, Inc. |
Phosphonate analogs of antimetabolites
|
|
BRPI0417988A
(pt)
|
2003-12-22 |
2007-04-27 |
Gilead Sciences Inc |
análogos de fosfonato antivirais
|
|
DE10361932A1
(de)
*
|
2003-12-30 |
2005-07-28 |
Celanese Ventures Gmbh |
Protonenleitende Membran und deren Verwendung
|
|
DE10361832A1
(de)
*
|
2003-12-30 |
2005-07-28 |
Celanese Ventures Gmbh |
Protonenleitende Membran und deren Verwendung
|
|
PT2258376T
(pt)
|
2004-07-27 |
2019-05-31 |
Gilead Sciences Inc |
Análogos fosfonatados de compostos inibidores do vih
|
|
EP1933848A2
(en)
*
|
2005-10-06 |
2008-06-25 |
Innate Pharma |
Phosphoantigen salts of organic bases and methods for their crystallization
|
|
US20090111774A1
(en)
*
|
2007-06-01 |
2009-04-30 |
Luitpold Pharmaceuticals, Inc. |
Pmea lipid conjugates
|
|
CN104324044A
(zh)
*
|
2008-02-15 |
2015-02-04 |
微量医疗技术有限公司 |
制造核苷四磷酸类似物的方法
|
|
BRPI0915878A2
(pt)
|
2008-07-08 |
2015-11-03 |
Gilead Sciences Inc |
sais ou hidratos de compostos inibidores de hiv, seu uso e composição farmacêutica que os compreende
|
|
EP2447274B1
(en)
|
2008-10-24 |
2017-10-04 |
Ionis Pharmaceuticals, Inc. |
Oligomeric compounds and methods
|
|
WO2011139702A2
(en)
|
2010-04-28 |
2011-11-10 |
Isis Pharmaceuticals, Inc. |
Modified nucleosides and oligomeric compounds prepared therefrom
|
|
WO2011139695A2
(en)
|
2010-04-28 |
2011-11-10 |
Isis Pharmaceuticals, Inc. |
Modified 5' diphosphate nucleosides and oligomeric compounds prepared therefrom
|
|
WO2011139699A2
(en)
|
2010-04-28 |
2011-11-10 |
Isis Pharmaceuticals, Inc. |
5' modified nucleosides and oligomeric compounds prepared therefrom
|
|
WO2014160200A1
(en)
*
|
2013-03-13 |
2014-10-02 |
Dana-Farber Cancer Institute, Inc. |
Ras inhibitors and uses thereof
|
|
LT3399984T
(lt)
|
2016-01-08 |
2023-11-10 |
Arcus Biosciences, Inc. |
5'-nukleotidazės, ekto moduliatoriai ir jų panaudojimas
|
|
CN110022881B
(zh)
*
|
2016-11-18 |
2023-05-02 |
艾库斯生物科学有限公司 |
Cd73介导的免疫抑制的抑制剂
|
|
PT3661937T
(pt)
|
2017-08-01 |
2021-09-24 |
Gilead Sciences Inc |
Formas cristalinas de ((s)-((((2r,5r)-5-(6-amino-9h-purin-9-il)-4-fluoro-2,5-dihidrofurano-2-il)oxi)metil)(fenoxi)fosforil)-l-alaninato de etil (gs-9131) para tratamento de infeções virais
|
|
WO2020210970A1
(en)
*
|
2019-04-16 |
2020-10-22 |
Bioardis Llc |
Imidazotriazine derivatives as cd73 inhibitors
|
|
US11633416B1
(en)
|
2020-03-06 |
2023-04-25 |
Arcus Biosciences, Inc. |
Oral formulations of CD73 compounds
|